JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB79654

Biotin Anti-HMW Kininogen antibody

Be the first to review this product! Submit a review

|

(1 Publication)

Rabbit Polyclonal Kininogen antibody - conjugated to Biotin. Suitable for IP, ELISA, WB, RIA and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Native Full Length Protein corresponding to Human KNG1.

View Alternative Names

BDK, KNG, KNG1, Kininogen-1, Alpha-2-thiol proteinase inhibitor, Fitzgerald factor, High molecular weight kininogen, Williams-Fitzgerald-Flaujeac factor, HMWK

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Conjugation

Biotin

Excitation/Emission
Carrier free

No

Reacts with

Human

Applications

RIA, WB, IP, ELISA

applications

Immunogen

Native Full Length Protein corresponding to Human KNG1.

P01042

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "RIA" : {"fullname" : "Radioimmunoassay", "shortname":"RIA"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "ELISA-species-checked": "guaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p></p>", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "RIA-species-checked": "guaranteed", "RIA-species-dilution-info": "", "RIA-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein G
Storage buffer
pH: 7.5 Preservative: 0.01% Thimerosal (merthiolate) Constituents: PBS, 50% Glycerol (glycerin, glycerine)
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

High molecular weight kininogen also known as HMW kininogen or HK is a glycoprotein with a molecular mass of about 120 kDa. It is synthesized in the liver and circulates in the bloodstream. It serves as a precursor to bradykinin a peptide involved in inflammation blood pressure regulation and pain. HMW kininogen also acts as a cofactor for kallikrein activation playing a significant role in the intrinsic pathway of blood coagulation. Additionally it exists as part of a quaternary structure with other plasma proteins functioning within the circulatory system.
Biological function summary

This kininogen is essential for the kallikrein-kinin system and interacts with various cell surface receptors to trigger diverse cellular responses. It is part of a complex that includes prekallikrein and factor XII facilitating the assembly and activation of these components on negatively charged surfaces. This interaction supports the generation of bradykinin which mediates vasodilation and increases vascular permeability critical processes in inflammatory responses. The multifunctional nature of HMW kininogen allows it to contribute broadly to the regulation of hemostasis and innate immunity.

Pathways

HMW kininogen is linked notably to both the contact activation pathway and the renin-angiotensin system. In the contact activation pathway it associates closely with prekallikrein and factor XII promoting the conversion of prekallikrein to kallikrein and subsequent steps in coagulation. In the renin-angiotensin system bradykinin produced from HMW kininogen modulates blood pressure through interactions with ACE (angiotensin-converting enzyme) showcasing the enzyme's relationship with these pathways. These pathways position HMW kininogen at a critical junction of cardiovascular and immune system regulation.

HMW kininogen associates with conditions such as hereditary angioedema and cardiovascular disorders. Hereditary angioedema results from bradykinin overproduction implicating HMW kininogen in its pathophysiology with links to defects in C1 inhibitor another regulatory protein. Cardiovascular disorders may involve aberrant bradykinin production and metabolism where HMW kininogen plays a role through interaction with the renin-angiotensin system. Aberrations in its function or expression can contribute toward the pathogenesis of these conditions highlighting the need for further research into its clinical implications.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Kininogens are inhibitors of thiol proteases. HMW-kininogen plays an important role in blood coagulation by helping to position optimally prekallikrein and factor XI next to factor XII; HMW-kininogen inhibits the thrombin- and plasmin-induced aggregation of thrombocytes. LMW-kininogen inhibits the aggregation of thrombocytes. LMW-kininogen is in contrast to HMW-kininogen not involved in blood clotting.. Bradykinin. The active peptide bradykinin is a potent vasodilatator that is released from HMW-kininogen shows a variety of physiological effects : (A) influence in smooth muscle contraction, (B) induction of hypotension, (C) natriuresis and diuresis, (D) decrease in blood glucose level, (E) it is a mediator of inflammation and causes (E1) increase in vascular permeability, (E2) stimulation of nociceptors (4E3) release of other mediators of inflammation (e.g. prostaglandins), (F) it has a cardioprotective effect (directly via bradykinin action, indirectly via endothelium-derived relaxing factor action).
See full target information KNG1

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Journal of immunology (Baltimore, Md. : 1950) 195:3596-604 PubMed26371246

2015

The Levels of the Lectin Pathway Serine Protease MASP-1 and Its Complex Formation with C1 Inhibitor Are Linked to the Severity of Hereditary Angioedema.

Applications

Unspecified application

Species

Unspecified reactive species

Cecilie Bo Hansen,Dorottya Csuka,Lea Munthe-Fog,Lilian Varga,Henriette Farkas,Karin Møller Hansen,Claus Koch,Karsten Skjødt,Peter Garred,Mikkel-Ole Skjoedt
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com